• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sweet-Like Eruption Associated With Obinutuzumab Therapy for Chronic Lymphocytic Leukemia.

作者信息

Korman Abraham M, Hastings Justin G, Byrd John C, Kaffenberger Benjamin H

机构信息

Division of Dermatology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus2Department of Dermatology, University of Cincinnati College of Medicine, Cincinnati, Ohio.

Division of Dermatology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus.

出版信息

JAMA Dermatol. 2017 Jan 1;153(1):108-110. doi: 10.1001/jamadermatol.2016.3355.

DOI:10.1001/jamadermatol.2016.3355
PMID:27892987
Abstract
摘要

相似文献

1
Sweet-Like Eruption Associated With Obinutuzumab Therapy for Chronic Lymphocytic Leukemia.与奥滨尤妥珠单抗治疗慢性淋巴细胞白血病相关的类甜疹
JAMA Dermatol. 2017 Jan 1;153(1):108-110. doi: 10.1001/jamadermatol.2016.3355.
2
Obinutuzumab monotherapy in previously untreated chronic lymphocytic leukemia.奥比妥珠单抗单药治疗初治慢性淋巴细胞白血病
Leuk Lymphoma. 2018 Sep;59(9):2258-2260. doi: 10.1080/10428194.2017.1410890. Epub 2017 Dec 18.
3
Evaluation of safety outcomes with transitioning obinutuzumab from standard rate to short duration infusion in patients with chronic lymphocytic leukemia.评估慢性淋巴细胞白血病患者将奥妥珠单抗从标准输注速率转换为短疗程输注后的安全性结果。
Leuk Lymphoma. 2024 Aug;65(8):1198-1199. doi: 10.1080/10428194.2024.2341999. Epub 2024 Apr 22.
4
Obinutuzumab for the treatment of chronic lymphocytic leukemia and other B-cell lymphoproliferative disorders.奥滨尤妥珠单抗用于治疗慢性淋巴细胞白血病及其他B细胞淋巴增殖性疾病。
Expert Opin Biol Ther. 2017 Nov;17(11):1463-1470. doi: 10.1080/14712598.2017.1377178. Epub 2017 Sep 11.
5
Venetoclax and obinutuzumab for frontline treatment of chronic lymphocytic leukemia.维奈托克联合奥滨尤妥珠单抗一线治疗慢性淋巴细胞白血病。
Blood. 2019 Nov 14;134(20):1691-1696. doi: 10.1182/blood.2019001750.
6
Obinutuzumab use complicated by progressive multifocal leukoencephalopathy in a patient with chronic lymphocytic leukemia: a case report.一名慢性淋巴细胞白血病患者使用奥滨尤妥珠单抗并发进行性多灶性白质脑病：病例报告
Acta Neurol Belg. 2021 Jun;121(3):781-783. doi: 10.1007/s13760-020-01520-1. Epub 2020 Oct 15.
7
Progressive multifocal leukoencephalopathy developing after obinutuzumab treatment for chronic lymphocytic leukemia.在使用奥滨尤妥珠单抗治疗慢性淋巴细胞白血病后发生的进行性多灶性白质脑病。
Ann Hematol. 2019 Jun;98(6):1509-1510. doi: 10.1007/s00277-018-3552-x. Epub 2018 Nov 13.
8
A phase I-II clinical trial of the anti-CD74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach.抗CD74单克隆抗体米拉妥珠单抗用于难治性慢性淋巴细胞白血病体弱患者的I-II期临床试验：基于患者的研究方法
Br J Haematol. 2018 Jul;182(1):125-128. doi: 10.1111/bjh.14726. Epub 2017 May 3.
9
Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab.CD20表达及其他预处理风险因素在接受奥滨尤妥珠单抗治疗的慢性淋巴细胞白血病患者发生输注相关反应中的作用
Leukemia. 2016 Aug;30(8):1763-6. doi: 10.1038/leu.2016.41. Epub 2016 Mar 4.
10
Pembrolizumab-induced dermatomyositis in a patient with metastatic melanoma.帕博利珠单抗诱发转移性黑色素瘤患者发生皮肌炎。
Eur J Cancer. 2018 Nov;104:227-230. doi: 10.1016/j.ejca.2018.08.021. Epub 2018 Oct 12.